Reliability and Validity of iscorEB (Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa).
| Author | |
|---|---|
| Abstract |
:
Epidermolysis bullosa (EB) is a group of rare and currently incurable genetic blistering disorders. As more pathogenic driven therapies are being developed, the need for EB-specific validated outcomes measures designed for use in clinical trials is becoming important. |
| Year of Publication |
:
2018
|
| Journal |
:
The British journal of dermatology
|
| Date Published |
:
2018
|
| ISSN Number |
:
0007-0963
|
| URL |
:
http://dx.doi.org/10.1111/bjd.16350
|
| DOI |
:
10.1111/bjd.16350
|
| Short Title |
:
Br J Dermatol
|
| Download citation |
